There’s no doubt that Aussies love a good celebration. We’re all in when it comes to the weekend, and most of us can’t go past a Christmas celebration without a little bit of overindulging. But all this comes at a cost, and it’s taking a massive toll on our waistline.
Ravulizumab Showed Preclinical Promise for ALS. What Happened?
Ravulizumab (Ultomiris), a terminal complement C5 inhibitor, did not improve functional status and survival in patients with amyotrophic lateral sclerosis (ALS), the phase III CHAMPION-ALS
September 12, 2023